Literature DB >> 30854518

Etiology of Chronic Liver Disease in Ethiopia: A Case Control Study with Special Reference to Viral Hepatitis and Alcohol.

Semira Abdelmenan1, Abate Banes2, Yemane Berhane1, Markos Abebe3, J H Wandall4.   

Abstract

INTRODUCTION: Chronic diseases of the liver are a global health problem with high morbidity and mortality. Viral hepatitis is the predominant cause for liver disease in low and middle-income countries. Viral hepatitis is also frequent in high-income countries but mainly as a complication to drug abuse or iatrogenic to treatment. In high-income countries non-fatty-liver-disease and complications to alcohol consumption are the most frequent etiology of liver disease. Viral hepatitis B and C is prevalent in Ethiopia but there are only few studies done in relation to chronic liver disease and a relationship between the increasing alcohol consumption and chronic liver disease.
OBJECTIVE: A The aim of the study was to assess the association between chronic liver disease in Ethiopia and infection with viral hepatitis and possible relation to alcohol consumption. METHODS AND MATERIAL: An unmatched case control study was conducted in Addis Ababa. Cases were chronic liver disease patients (n = 812) and controls were patients without liver disease (n = 798). Data were collected from the records of patients treated at a specialized clinic of Gastrsoenterology and Hepatology in Addis Ababa from 1st January 2013 - 31st, December 2013.
RESULTS: The odds of having hepatitis infection among chronic liver disease was AOR = 100.96, (95%CI: 62.15 - 164.02) for HBV and AOR = 59.2, (95%CI: 27.23 - 130.9) for HCV. Consumption of alcohol was associated with chronic liver disease (OR: 8.23 95%CI: 3.76 - 12.70). Liver enzymes were elevated significantly in patients with hepatitis and alcohol consumption compared to patients without alcohol consumption.
CONCLUSION: Viral hepatitis infections are strongly associated with chronic liver disease. Prevention of viral hepatitis infections and control of alcohol consumption need to be strengthened in order to reduce the burden of chronic liver disease in Ethiopia.

Entities:  

Keywords:  Alcohol; Chronic Liver Disease; Ethiopia; Hepatitis B; Hepatitis C; Non-Communicable Diseases

Year:  2018        PMID: 30854518      PMCID: PMC6402780     

Source DB:  PubMed          Journal:  EC Gastroenterol Dig Syst


  18 in total

Review 1.  Accuracy of ultrasound to identify chronic liver disease.

Authors:  Richard Allan; Kerry Thoirs; Maureen Phillips
Journal:  World J Gastroenterol       Date:  2010-07-28       Impact factor: 5.742

2.  Prevalence of HBV and HCV dual infection in patients on haemodialysis.

Authors:  G A Reddy; K V Dakshinamurthy; P Neelaprasad; T Gangadhar; V Lakshmi
Journal:  Indian J Med Microbiol       Date:  2005-01       Impact factor: 0.985

3.  Natural history of hepatitis B and C in renal allograft recipients.

Authors:  Adriana Aroldi; Pietro Lampertico; Giuseppe Montagnino; Patrizia Passerini; Margherita Villa; Maria R Campise; Giovanna Lunghi; Antonio Tarantino; Bruno M Cesana; PierGiorgio Messa; Claudio Ponticelli
Journal:  Transplantation       Date:  2005-05-15       Impact factor: 4.939

4.  HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt.

Authors:  A Paez Jimenez; N Sharaf Eldin; F Rimlinger; M El-Daly; H El-Hariri; M El-Hoseiny; A Mohsen; A Mostafa; E Delarocque-Astagneau; M Abdel-Hamid; A Fontanet; M K Mohamed; V Thiers
Journal:  Gut       Date:  2010-11       Impact factor: 23.059

5.  Hepatitis B seropositivity among chronic liver disease patients in Hazara division Pakistan.

Authors:  Taher Salim Khan; Farhat Rizvi
Journal:  J Ayub Med Coll Abbottabad       Date:  2003 Jul-Sep

6.  Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control.

Authors:  A Abebe; D J Nokes; A Dejene; F Enquselassie; T Messele; F T Cutts
Journal:  Epidemiol Infect       Date:  2003-08       Impact factor: 2.451

7.  Chronic liver disease in Ethiopia: a clinical study with emphasis on identifying common causes.

Authors:  E Tsega; E Nordenfelt; B G Hansson; B Mengesha; J Lindberg
Journal:  Ethiop Med J       Date:  1992-04

Review 8.  Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa.

Authors:  Valsa Madhava; Christine Burgess; Ernest Drucker
Journal:  Lancet Infect Dis       Date:  2002-05       Impact factor: 25.071

9.  Prevalence and risk factors of Hepatitis C among individuals presenting to HIV testing centers, Hawassa city, Southern Ethiopia.

Authors:  Addisu Alemayehu; Yayehyirad Tassachew; Zufan Sisay; Techalew Shimelis
Journal:  BMC Res Notes       Date:  2011-06-15

10.  Hepatitis B virus infection among medical aste handlers in Addis Ababa, Ethiopia.

Authors:  Yitayal Shiferaw; Tamrat Abebe; Adane Mihret
Journal:  BMC Res Notes       Date:  2011-11-03
View more
  4 in total

1.  Increasing Burden of Acute Hepatitis A among Ethiopian Children, Adolescents, and Young adults: A Change in Epidemiological Pattern and Need for Hepatitis A Vaccine.

Authors:  Abate Bane; Amir Sultan; Rabia Ahmed
Journal:  Ethiop J Health Sci       Date:  2022-03

2.  Prevalence of HIV and Its Co-Infection with Hepatitis B/C Virus Among Chronic Liver Disease Patients in Ethiopia.

Authors:  Yayehyirad Tassachew; Tamrat Abebe; Yeshambel Belyhun; Tezazu Teffera; Abate Bane Shewaye; Hailemichael Desalegn; Henok Andualem; Abiy Kinfu; Andargachew Mulu; Adane Mihret; Rawleigh Howe; Abraham Aseffa
Journal:  Hepat Med       Date:  2022-05-13

Review 3.  Chronic Liver Disease in Ethiopia with a Particular Focus on the Etiological Spectrums: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Behailu Terefe Tesfaye; Temesgen Mulugeta Feyissa; Azmeraw Bekele Workneh; Esayas Kebede Gudina; Mengist Awoke Yizengaw
Journal:  Can J Gastroenterol Hepatol       Date:  2021-11-23

4.  Occult hepatitis B virus infection among patients with chronic liver disease of unidentified cause, Addis Ababa Ethiopia.

Authors:  Selam Bogale Gissa; Mengistu Erkie Minaye; Biruk Yeshitela; Gizachew Gemechu; Abebech Tesfaye; Dawit Hailu Alemayehu; Abel Shewaye; Amir Sultan; Adane Mihret; Andargachew Mulu
Journal:  Sci Rep       Date:  2022-08-01       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.